Brad C. Hansen

Brad C. Hansen

Auto-generated profile, based on publicly available information

Brad C. Hansen

University of Washington

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BHBrad C. Hansen
Brad C. Hansen
CAChristopher M. Arian
Christopher M. Arian
YZYuting Zeng
Yuting Zeng
MTMeg G. Takezawa
Meg G. Takezawa
ATAshleigh B. Theberge
Ashleigh B. Theberge
EKEdward Kelly
Edward Kelly
Accelerating development of complex in vitro models (CIVMs) drives a need for additional methods to characterize these systems for use in toxicology and drug development. Relative to traditional cell culture, CIVMs can use a lower number of cells, are cultured for longer periods of time, and typically involve engineered 3-D cell organization. Standard single-cell assessment tools are not conducive to these types of complex models due to cell isolation stress, cell loss, and high cost. In this report, we benchmark RNA-seq deconvolution, which utilizes publicly available scRNA-seq datasets to predict cell proportions from bulk RNA-seq data derived from two CIVMs: a stem-cell-based human intestinal organoid CIVM and a neonatal rodent testis CIVM. We consider the impact of multiple imputation methods for scRNA-seq to restore the gene distribution of the original tissue and benchmark multiple deconvolution methods. The accuracy of deconvolution methods varied significantly in our analyses but provided valuable information on the emergence of an enterocyte cell population from the LGR5+ crypt stem cells following differentiation in the intestinal organoid CIVM. In the testis CIVM, deconvolution indicated that a small population of germ cells were retained over time, peritubular myoid cells proliferated over time, and that Leydig cell estimates remained stable with physiologically relevant hormone stimulation. In our analysis, using imputed single-cell references improved deconvolution accuracy. Deconvolution can be a useful tool for novel CIVM characterization, especially with rapidly growing libraries of single-cell data across tissues and developmental time.

26 September 2025 in Toxicological Sciences
Verified
Journal Article
Closed access
BHBrad C Hansen
Brad C Hansen
KAKayenat S Aryeh
Kayenat S Aryeh
LLLillian X Lindell
Lillian X Lindell
GLGabriel K Lau
Gabriel K Lau
TNTristan M Nicholson
Tristan M Nicholson
EKEdward Kelly
Edward Kelly
There is a paucity of in vitro models to study the male reproductive system. Proper function of the reproductive system is critical for endocrine function, growth and development, and fertility. Without practical in vitro screening models, reproductive toxicities can be missed in early drug development or standard toxicological batteries. Successful in vitro models of the male reproductive system need to recapitulate the dynamic nature of the testis, considering the formation of the testicular niches from gonadal differentiation through puberty and the post-pubertal activity of the paracrine and endocrine signals that support spermatogenesis. In vitro approaches are reviewed that model primordial germ cell differentiation, gonadal morphogenesis, fetal steroidogenesis, neonatal reproductive development, and adult testicular niche dynamics to present opportunities for inclusion of male reproductive toxicity screening within a toxicological battery. The utility of cells derived from model organisms, differentiated from induced pluripotent stem cells, and obtained from donated human tissue is discussed. The field of reproductive and developmental toxicology is primed for expansion in in-vitro model availability as complex in-vitro model development continues to accelerate, and fit-for-purpose model approaches are adopted in toxicological and drug development pipelines. This review highlights the current limitations and emerging opportunities in male reproductive in vitro models, providing a roadmap for integrating these systems into toxicology testing and drug development workflows. It highlights the need for developmentally benchmarked, physiologically relevant, and multicellular models to fill existing gaps and improve translatability.

31 December 2025 in bioRxiv
Verified
Preprint
Open access
BHBrad C Hansen
Brad C Hansen
SHSarah A Hatem
Sarah A Hatem
LHLucas Huang
Lucas Huang
JAJohn K Amory
John K Amory
EFElaine M Faustman
Elaine M Faustman
EKEdward Kelly
Edward Kelly
Spermatogonial differentiation is controlled by distinct spatial and temporal activities of metabolizing enzymes and signaling molecule formation. In vitro models are reductionist ways to examine the interactions between Sertoli cells and spermatogonial stem cells, which may be therapeutic targets for infertility that cause non-obstructive azoospermia, due to either Sertoli-cell only syndrome, hypospermatogenesis or maturation arrest. Here, we find that nanomolar doses of isotretinoin are sufficient to drive Stra8 expression in vitro, an interaction that is both dose-dependent and inhibitable. We compare complex in vitro models (CIVMs) seeded from cells isolated post-natal day 5 (PND 5) and post-natal day 10 (PND 10) Sprague Dawley rat testis. The CIVMs maintain metabolic capacity to produce bioactive retinoids form retinol. We also investigate the impact of common media supplementations on spermatogonial phenotype and find that they can impact the expression of Stra8 and Plzf as markers of early differentiating and undifferentiated spermatogonia, respectively. These results highlight the power of in vitro models to investigate the dynamics of the spermatogonial niche.